Status:
COMPLETED
Study of a Polymorphism in Patients With Prostate Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer and from healthy participants in the laboratory may help doctors learn more about changes that may occur in DNA. PURPOSE: This laborator...
Detailed Description
OBJECTIVES: Primary * Determine the incidence of the D104N COL18A1 polymorphism in patients with prostate cancer. Secondary * Determine the incidence of this polymorphism in African-American patie...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of prostate cancer OR healthy participant
- Patient enrolled on an IRB-approved clinical trial at the National Cancer Institute or Northwestern University, including, but not limited to, any of the following:
- NCI-99-C-0052
- NCI-95-C-0178
- NCI-00-C-003
- NCI-00-C-0080
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00900185
Last Update
April 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.